Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Estrogen Receptor
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
S-equol
(AUS-131) / Ausio Pharma
Donesta
(estetrol) / Mithra, Pantarhei
Vagitocin
(oxytocin topical) / Peptonic Medical
ZN-c5
/ Zentalis Pharma
afimoxifene
/ Besins Healthcare
brilanestrant
(GDC-0810) / Roche
Capesaris
(GTx-758) / Oncternal Therap
Seala
(VG101) / Bionovo
erteberel
(LY500307) / Eli Lilly
fispemifene
(HM-101) / Seelos Therap
genistein nanosuspension
(BIO 300) / Humanetics
Depo-Estradiol
(estradiol cypionate) / Pfizer
H3B-6545
/ Eisai
HRS-8080
/ Jiangsu Hengrui Pharma
Rotundine
(levo-tetrahydropalmatine) / Second Affiliated Hospital of Guangzhou Medical University, National Institute on Drug Abuse, University of Maryland
estrogen/progesterone intravaginal ring
(DARE-HRT1) / Daré Biosci
DZD3969
/ AstraZeneca
TAS-108
/ Otsuka, Nobelpharma, SRI International
borestrant
(ZB716) / Zenopharm, EnhancedBio
estradiol transdermal gel
(BHR-200) / Besins Healthcare
lasofoxifene topical
(AZU-101) / Azure Biotech
tamoxifen vaginal
(DARE-VVA1) / Daré Biosci
zuclomiphene
(VERU-944) / Veru Inc
